Risk factors associated with prognosis of patients with medication-related osteonecrosis of the jaw

被引:0
|
作者
Tadokoro, Yoshiaki [1 ]
Hasegawa, Takumi [1 ,2 ]
Takeda, Daisuke [1 ]
Murakami, Aki [1 ]
Yatagai, Nanae [1 ]
Arimoro, Satomi [1 ]
Iwata, Eiji [1 ]
Saito, Izumi [1 ]
Kusumoto, Junya [1 ]
Akashi, Masaya [1 ]
机构
[1] Kobe Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Kobe, Japan
[2] Kobe Univ, Grad Sch Med, Dept Oraland Maxillofacial Surg, Kobe 6500017, Japan
来源
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2024年 / 46卷 / 02期
关键词
medication-related osteonecrosis of the jaw; osteolysis; prognosis; risk factors; sequestration; BISPHOSPHONATE-RELATED OSTEONECROSIS; MULTIPLE-MYELOMA; CANCER-PATIENTS; POSITION PAPER; MANAGEMENT; DENOSUMAB;
D O I
10.1002/hed.27574
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Objectives: Medication-related osteonecrosis of the jaw (MRONJ) is a severe adverse effect of antiresorptive and/or antiangiogenic agents. As the treatment application for MRONJ is controversial, we aimed to identify the risk factors for poor prognosis and to help determine appropriate management.Methods: This study included 119 patients. Relevant clinical data were obtained for all the patients. In computed tomography images, osteosclerosis, osteolysis, cortical perforation (buccal or lingual), periosteal reaction, and sequestration were evaluated.Results: Multivariate analyses showed statistically significant associations between poor prognosis in patients with MRONJ and conservative treatment alone (hazard ratio [HR] 1.89), osteolysis (HR 4.67), and the absence of sequestration (HR 5.33).Conclusions: Conservative treatment alone without clear objectives needs to be avoided, and osteolytic change could be the criteria for surgical intervention. As the boundary between the lesion and vital bone is indistinct, we recommend extensive surgery in cases with unpredictable sequestration.
引用
收藏
页码:282 / 290
页数:9
相关论文
共 50 条
  • [1] Oral risk factors associated with medication-related osteonecrosis of the jaw in patients with cancer
    Ueda, Nobuhiro
    Aoki, Kumiko
    Shimotsuji, Hiroko
    Nakashima, Chie
    Kawakami, Mao
    Imai, Yuichiro
    Kirita, Tadaaki
    JOURNAL OF BONE AND MINERAL METABOLISM, 2021, 39 (04) : 623 - 630
  • [2] Oral risk factors associated with medication-related osteonecrosis of the jaw in patients with cancer
    Nobuhiro Ueda
    Kumiko Aoki
    Hiroko Shimotsuji
    Chie Nakashima
    Mao Kawakami
    Yuichiro Imai
    Tadaaki Kirita
    Journal of Bone and Mineral Metabolism, 2021, 39 : 623 - 630
  • [3] The Frequency of Medication-related Osteonecrosis of the Jaw and its Associated Risk Factors
    Dodson, Thomas B.
    ORAL AND MAXILLOFACIAL SURGERY CLINICS OF NORTH AMERICA, 2015, 27 (04) : 509 - +
  • [4] Risk factors associated with onset of medication-related osteonecrosis of the jaw in patients treated with denosumab
    Alexander Wick
    Philipp Bankosegger
    Sven Otto
    Bettina Hohlweg-Majert
    Timm Steiner
    Florian Probst
    Oliver Ristow
    Christoph Pautke
    Clinical Oral Investigations, 2022, 26 : 2839 - 2852
  • [5] Risk factors associated with onset of medication-related osteonecrosis of the jaw in patients treated with denosumab
    Wick, Alexander
    Bankosegger, Philipp
    Otto, Sven
    Hohlweg-Majert, Bettina
    Steiner, Timm
    Probst, Florian
    Ristow, Oliver
    Pautke, Christoph
    CLINICAL ORAL INVESTIGATIONS, 2022, 26 (03) : 2839 - 2852
  • [6] Risk factors of medication-related osteonecrosis of the jaw: A clinical investigation
    Komatsu, Yuko
    Kawai, Tadashi
    Hirano, Taifu
    Hoshi, Isao
    Yamaya, Genki
    Ogawa, Atsushi
    Chiba, Toshimi
    Yamada, Hiroyuki
    JOURNAL OF STOMATOLOGY ORAL AND MAXILLOFACIAL SURGERY, 2024, 125 (06)
  • [7] Prognostic factors of the medication-related osteonecrosis of the jaw
    Szentpeteri Szofia
    Restar Laszlo
    Nemeth Zsolt
    Vaszilko Mihaly
    ORVOSI HETILAP, 2020, 161 (08) : 283 - 289
  • [8] Prognosis of Medication-Related Osteonecrosis of the Jaw with Surgical Treatment
    Kobayashi, Eizaburo
    Takahashi, Haruka
    Igarashi, Kensuke
    Katagiri, Hiroki
    Haga-Tsujimura, Maiko
    Ogura, Ichiro
    Nakahara, Ken
    Tanaka, Akira
    JOURNAL OF HARD TISSUE BIOLOGY, 2022, 31 (01) : 39 - 46
  • [9] Medication-related osteonecrosis of the jaw associated with aflibercept
    Zarringhalam, P.
    Brizman, E.
    Shakib, K.
    BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 2017, 55 (03): : 314 - 315
  • [10] Preventive Strategies for Patients at Risk of Medication-related Osteonecrosis of the Jaw
    Goodday, Reginald H.
    ORAL AND MAXILLOFACIAL SURGERY CLINICS OF NORTH AMERICA, 2015, 27 (04) : 527 - +